Sort   by:  
 Page size 
The lack of biomarkers for early diagnosis, clinical stratification and to monitor treatment response has hampered the development of new therapies for amyotrophic lateral sclerosis (ALS), a clinically heterogeneous neurodegenerative disorder with a variable site of disease initiation and rate of pr...
ORGANISM(S): Homo sapiens (Human) 
2020-07-30 | PXD020493 | Pride
the project aim was to evaluate the composition of circulating protein aggregates and compare it between patients affectd with ALS and healthy controls
ORGANISM(S): Homo sapiens (Human) 
2021-07-19 | PXD018923 | Pride
Sort   by:  
 Page size